Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients

Nephrol Dial Transplant. 2022 Feb 25;37(3):602-604. doi: 10.1093/ndt/gfab321.

Naomi Nacasch¹, Keren Cohen-Hagai^{1

2}, Sydney Benchetrit^{1

2}, Tali Zitman-Gal^{1

2}, Yael Einbinder^{1

2}, Daniel Erez^{2

3}, Tzipi Hornik-Lurie⁴, Shira Goldman^{5

2}, Tatiana Tanasiychuk⁶, Victor Frajewicki⁶, Sophie Magen^{7

8}, Yonit Wiener-Well^{9

8}, Alon Bnaya^{10

8}, Linda Shavit^{10

8}

¹ Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel.
⁴ Data Research Department, Meir Medical Center, Kfar Saba, Israel.
⁵ Department of Nephrology and Hypertension, Rabin Medical Center, Pathach Tikva, Israel.
⁶ Department of Nephrology and Hypertension, Carmel Medical Center, Haifa, Israel.
⁷ Clinical Endocrinology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel.
⁸ Hebrew University of Jerusalem, Jerusalem, Israel.
⁹ Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
¹⁰ Institute of Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.

No abstract available

Publication types